Autonomix Medical Completes GLP Study for FDA Submission
THE WOODLANDS, Texas, August 12, 2026 Autonomix Medical, Inc. announced the successful completion of a Good Laboratory Practice (GLP)...
Chronic Pain
Advertisement
Alliance for Building Better Medicine Secures $15.97M EDA Grant
RICHMOND, Va., July 20, 2026 Virginia’s Advanced Pharmaceutical Manufacturing (APM) Tech Hub has secured a $15.97 million investment from...
BIOTRONIK Neuro Launches AI-Powered Embrace One Platform
LAKE OSWEGO, Ore., July 20, 2026 BIOTRONIK Neuro has unveiled Embrace One® Proactive Intelligence, a proprietary artificial intelligence (AI)...
PainTEQ Unveils New SI Joint Clinical Evidence at ASPN
TAMPA, Fla., July 16, 2026 PainTEQ has unveiled new scientific evidence supporting its cortical-piercing posterior sacroiliac (SI) joint fixation...
Saluda Medical Receives FDA Approval for CAP24 Surgical Paddle Lead
Bloomington, Minnesota, USA | July 16, 2026 Saluda Medical announced that the U.S. Food and Drug Administration (FDA) has...
Advertisements
Merck’s KEYTRUDA Tops Chemo in dMMR Endometrial Cancer
RAHWAY, N.J., July 15, 2026 Merck has announced that its blockbuster PD-1 inhibitor KEYTRUDA® (pembrolizumab) achieved the primary endpoint...
Kelun-Biotech Advances SKB575 with China IND Approval
CHENGDU, China, July 15, 2026 Kelun-Biotech and Harbour BioMed have announced that China’s National Medical Products Administration (NMPA) has...
MAXONA Wins FDA IND Clearance for MAX-001 Phase 2 Trial
MALVERN, Pa., July 15, 2026 MAXONA Pharmaceuticals has received U.S. FDA Investigational New Drug (IND) clearance to initiate a...
Autonomix Secures Canadian Patent for Neural Sensing
THE WOODLANDS, Texas, July 13, 2026 Autonomix Medical announced the grant of Canadian Patent No. 3,158,197, titled “Endoscopic Sympathectomy...
HDT Bio Advances HDT-401 into Phase 1 Glioblastoma Trial
MONTREAL, Canada / SEATTLE, Washington, July 12, 2026 HDT Bio Corp. has launched a major Canadian clinical development initiative...
Advertisement
